INTRODUCTION
Tissue microarrarys (TMAs) permit the simultaneous comparison of the expression of a target gene across multiple tissues. TMAs have been widely used to identify disease marker genes (1) (2) (3) , analyze cancer pathogenesis (4-7), screen new drugs, and validate drug targets (8) (9) . Currently, most TMAs are made by coring cylindrical tissues from paraffin-embedded donor blocks and transferring cores into a paraffin-recipient block (10) . Although paraffin-embedded archived tissues have been widely used to prepare TMAs, some researchers are also using fresh frozen clinical tissues to make TMAs (11, 12) . Fresh frozen tissues may provide better starting materials to make TMAs. Recently, an optimum cutting temperature (OCT)-embedding method (13) was developed to prepare TMAs from fresh tissues. In this approach, fresh tissues were embedded in OCT in dry ice without fixation. The embedded tissues were cored and transferred into an OCT-recipient block for cryostat sectioning. In this protocol, the OCT matrix required all processing to be performed in dry ice. It was reported that dry ice frozen tissues may be too hard and brittle, making them difficult to core properly (14) ; also it may not be easy to pre-drill array cavities in the dry-ice frozen OCT recipient block (15) using arrayer machine. In this study, we designed a different method to prepare TMAs for frozen tissue samples. The method is centered on the design and use of a new recipient block that contains preformed array cavities. This recipient block can be used to array tissue cores at either room temperature or low temperature (-5° to -10°C). The new recipient block is fundamentally different in design and composition from both paraffinrecipient blocks (10) and OCT blocks (13) . After arraying frozen cored samples into the block, the block can be sectioned immediately using a cryostat microtome. TMAs made using this method maintained the integrity of RNAs and proteins. Our method provides an alternative tool to make high-quality TMAs from frozen clinical tissue samples.
MATERIALS AND METHODS

Design of the Array Recipient Block
A critical component of our method is the preparation of a new recipient block used to array cored frozen tissues. The matrix of the new block contains the following components [all obtained from Sigma-Aldrich (St. Louis, MO, USA)]: 0.2% formalin, 20% gelatin, 10% sucrose, 1% agarose, and 1× phosphate-buffered saline (PBS). The formalin is used to inhibit the growth of fungi and bacteria inside the pre-made gel matrix. Sucrose and gelatin were used so that the recipient block can be sectioned smoothly and easily. Array cavities in the block are made using a metal stamp mold and a small plastic box that acts as a jig to hold the mold in place ( Figure 1A ). The plastic box is used to retain the molten matrix, and the stamp mold with 8 × 12 steel pins is used to form the array cavities. Pins are 15 mm in length with a diameter of 1.5 mm. To prepare the recipient block, the mixture was melted by heating in a microwave oven and then poured into the cubic box. The steel mold is inserted into the molten matrix. The matrix is allowed to solidify, and the steel mold is manually removed from the matrix. Removal of the steel mold with 96 long pins then forms 96 long, cylindrical array cavities in the block.
Preparation of Tissue Microarray Slides
Different tissues, including fresh frozen mouse and human clinical tissues, have been tested for preparing TMAs. Frozen tissues were trimmed into small cubic blocks, followed by embedding in OCT compound in dry ice. Coring sites were selected by either 
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surface marking of the frozen blocks or overlay of stained sections described previously (10, 13) . A cylindrical thinwall needle (5.4-cm-long and inner diameter of 1.53 mm) and plunger (5.5-cm-long and inner diameter of 1.53 mm) were used for coring tissues and for transferring cored samples into array cavities in the recipient block, respectively. The coring needle has a flanged inner-tip chamber design so that the cored tissues have the uniform cylindrical column dimensions. Manual coring of tissues was conducted. The diameter of cored tissues was slightly larger than array cavity, which allowed the cored tissue to fit snugly inside the cavity to facilitate tissue sectioning. The coring and transferring was done at -5° to -10°C inside the cryostat microtome. This worked perfectly, and temperatures were well-balanced. At this temperature, it is easy to core and transfer tissue cores without compromising morphology and RNA/ protein quality. The cored tissues will not stick on the coring tube. After the recipient block was filled with cores, the block was then transferred into a cryostat microtome for sectioning. TMA sections at 6-10 μm were cut at -20°C and mounted on pre-coated glass slides. Prepared TMA blocks can be also preserved in the freezer at -80°C for months without compromising the quality of RNA, protein, and morphology.
Evaluation of TMA Quality Using In Situ Hybridization and Immunocytochemistry
The quality of TMA slides is evaluated based on the overall configuration, tissue/cell morphology, and RNA/protein quality. To evaluate TMA configurations and tissue morphology, slides were first fixed with 4% paraformaldehyde for 5-10 min, stained using hematoxylin and eosin (H&E) or cresyl violet, and observed under a microscope. RNA quality was evaluated by in situ detection of mRNA expressions for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and vasoactive intestinal polypeptide (VIP). Digoxigenin (DIG)-labeled GAPDH and VIP sense and antisense probes were transcribed from plasmid vectors containing GAPDH or VIP cDNAs.
Hybridization was done at 55°C for 16 h as previously described (16 
RESULTS AND DISCUSSION
Properties of Array Recipient Block and Tissue Microarray Slides
A new recipient block containing 96 array cylindrical holes was made in the array block at room temperature with the aid of a 96-pin steel stamp mold ( Figure  1A ). The new block matrix remains solid at room temperature and can be frozen on dry ice without any damage to the matrix ( Figure 1B ). After freezing the block, array cavities still retain their rounded shape and smoothness. Thin sections of 4-16 μm were successfully sliced from the matrix. Folding and cracking was not readily detectable in the sections. The sections could easily be mounted on coated glass slides, and a simple wash of the slide in 1× PBS completely removed the matrix from the glass slide, leaving behind only attached tissue cores. Ninety-six different tissue cores from both mouse and human organs was constructed. TMA slides at 6 μm were cut and stained using H&E and cresyl violet. Histological staining revealed a well-defined array configuration for all cores ( Figure 1C) . Each core displayed identical size and shape. Core-to-core spatial alignment was well maintained with an edgeto-edge spacing of approximately 0.4 mm. Overall, <1%-5% of tissue cores were lost during sectioning, mounting, and subsequent staining. Tissue and cell morphology were evaluated using three criteria: (i) integrity of tissue cores, (ii) integrity of cell shapes, and (iii) anatomical character of specific cell types in different organs ( Figure   1, D-F) . TMAs produced by our method exhibited a low incidence of folding and cracking within the cores of unfixed frozen tissues. Tissue cores maintained their original morphology, displaying sharp edges and integrated inner structures ( Figure 1D ). The overall anatomical pattern associated with pathological sample such as tumor tissue, was also well-maintained ( Figure  1E ). Inside each tissue core, cells maintained their regular shapes, with intact cell membrane and clear nuclei ( Figure 1F ). Morphological damages, such as empty holes or disassociated tissues, were not observed.
These results directly demonstrated that TMA slides prepared by our method have a well-defined array configuration and also exhibited clear cell morphology in normal and cancerous tissues. The manufacturing procedure of our TMA technology is simple and time-saving. TMA stamps are commercially available from Texas Instruments (Dallas, TX, USA) or from Lab Vision (Fremont, CA, USA). Based on these results, we believe that this ready-to-use recipient array block is successfully able to generate TMAs containing 96 tissue cores in this study. Additionally, this new TMA method is flexible enough to allow TMA blocks to be processed, so the number of tissue cores to be arrayed is changeable. We have successfully tested the feasibility of making a 384-core block (0.5 mm diameters) for high-throughput screening via our method. Although small tissue cores contain less biological and pathological information, double sampling of 0.5-mm tissue cores could include 95% representation of the original tumors (15) (16) (17) . The new technology also offers greater flexibility, since the pre-made recipient blocks sealed by parafilm or placed inside an airtight plastic bag can be stored at room temperature or at 4°C, and are ready-to-use whenever samples need to be cored and arrayed. This greatly minimizes block preparation time.
Assessing RNA and Protein Quality in Tissue Microarray Slides
To demonstrate if our method can preserve the integrity of RNAs in all the tissues used, we analyzed the expression of GAPDH and VIP mRNAs in our pre-made TMA slides. VIP mRNA expression was detected in cored human brain cortex, mouse hypothalamic ventral nucleus, and mouse cerebral cortex (Figure 2A) . The intensity of hybridization was strong in those regions. GAPDH mRNA expression was seen throughout the cores of mouse and human tissues. In general, GAPDH mRNA expression was moderate or low in most tissue types. The expression intensity varied depending on both organs and cell types. Some cells and pathological tissues exhibited very high GAPDH mRNA levels. For example, in normal mouse cerebellar cores, the expression of GAPDH mRNA in the Purkinje cells was much stronger than that found in the granule cell layer ( Figure  2B ). In frozen normal human brain tissues, strong GADPH hybridization signals were found in both brain hippocampal pyramidal cells and the cerebral cortex ( Figure 2C ). GAPDH expression was also widely detected in various cancer tissues. GAPDH levels in cancer cell regions were visibly higher than adjacent normal cell regions at the same tissue cores. For example, in ovary tumor cores, GAPDH mRNA expressions in cancer cell areas were much stronger than in normal cell areas ( Figure 2D ).
Immunocytochemistry was then used to confirm in situ hybridization data and to assess the quality of proteins in prepared TMA slides. We used GAPDH immunocytochemistry to confirm GAPDH mRNA hybridization result. Additionally, the expression levels of some representative proteins, such as CHAT, Bcl-2, cytokeratin, and Ras, were also examined. GAPDH protein was only detected in the cytoplasm of cells in all tissue cores, including normal and pathological cancer tissues. Its expression level varied depending on cell types and corresponded well with the expression patterns of GAPDH mRNAs. In most tissues, GAPDH protein was moderately detected. In tumor cores, GAPDH was more highly expressed in areas containing cancer cells than those of adjacent normal cells. For example, in ovary cancer tissues, GAPDH was highly expressed in cancer cells versus adjacent normal cells ( Figure 3A) . Cytokeratin proteins were strongly and widely detected in the mucous cell layer of cored colon cancer tissues ( Figure 3B) , intestine, and several other tissues. Bal-2 (not shown) and Ras ( Figure 3C ) proteincontaining cells were found in lung squamous cancer tissue. In the fresh frozen mouse intestine, choline acetyltransferase (ChAT)-containing cells were also identified in mouse intestine ( Figure 3D ). In general, almost all the immunoreactive cells are strongly labeled in the TMA slides prepared by our method.
One of the most important parameters to evaluate TMA quality is the integrities of RNAs and proteins. Our hybridization and immunocytochemical results clearly revealed wide expression of GAPDH mRNA and protein in almost all tissue cores. VIP mRNA and ChAT proteins were detected in brain cortex and mouse intestine. Cytokeratin and Ras proteins were also identified in the TMA slides. The expression patterns of those mRNAs and proteins displayed a cell and tissue-specific distribution pattern greatly consistent with previously published reports on the distribution of those genes (20) (21) (22) (23) (24) . These results suggest that our TMA technology is able to protect the integrity of RNAs and proteins during manufacturing TMA slides.
Although paraffin-embedded TMA slides provide better cell morphology than frozen TMA slides, it appears that paraffin-embedding technology may not be a good choice to prepare TMAs using frozen tissues. Thawing of frozen tissues during the manufacturing of TMA slides significantly damages tissue and cell morphology. However, the reality is that most fresh clinical tissues are quickly frozen in dry ice or liquid nitrogen after surgery. Under freezing condition, intracellular nucleic acids and proteins remain well-protected, yielding higher quality disease-related RNA and protein signals. Accordingly, frozen tissues provide a better starting material for making TMAs for drug screening, target validation, and biomarker identification. Our study confirms that higher quality RNAs and proteins are obtained in our TMA slides made from frozen clinical samples. Therefore, our TMA protocol provides a tool for directly using frozen tissue samples to produce high-quality TMA slides. Several years ago, one group reported using an OCT-based technique to prepare high-quality TMAs (13) . In that method, OCT was used as the array recipient block matrix. However, the use of OCT required that all experiments be carried out on dry ice, and all the array cavities cannot be made simultaneously. It also required the use of an expensive tissue microarray instrument. As compared with an OCTbased method, our TMA technology appears to be relative easy, timesaving and cost-efficient. Therefore, our method provides a more feasible way for general research communities to prepare high-quality TMA slides from frozen tissue samples.
